pharma · Bladder (Urothelial, Transitional Cell) Cancer · Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) · RLMD
RELMADA THERAPEUTICS
RELMADA THERAPEUTICS, INC.
RELMADA THERAPEUTICS is a pharma organization headquartered in Coral Gables, USA. It trades on NYSE under ticker RLMD. Primary therapeutic focus areas include Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urot
Coral Gables, USA HQ
2004 Founded
33 Employees
Public company Type
RLMD · NYSE Ticker
Company details
- Status
- Public
- HQ
- Coral Gables, USA
- Founded
- 2004
- Employees
- 33
- Programs
- 6
- Drugs
- 5
- Patents
- 7
REL-1017
Phase 2 · small molecule · Depressive Disorder, Major
REL-1017 for Depressive Disorder, Major is a Phase 2 program (small_molecule) at RELMADA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Internal code REL-1017-202
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- RELMADA THERAPEUTICS, INC.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Depressive Disorder, Major
- Status
- completed
- Trials
- 1